About Event

Welcome to the Future of Cell Therapy

With the tumour microenvironment being one HUGE barrier to clinical success, enabling next generation developments and innovative technology is the only way to conquer solid tumours. 

Unlike the flagship Boston summit which covers development end-to-end, the 6th CAR-TCR Summit Europe is the only industry-dedicated forum focused only on next-generation innovations in cell therapies. Join over 250 stakeholders accelerating the 3rd, 4th, and 5th generation of adoptive cell therapies to the clinic across 3 days of carefully curated sessions. 

What Will You Learn?

Novel
Platforms

Leverage
innovative technology to enhance cell function & improve therapeutic efficacy

Develop
cellular therapies with improved tumour targeting
 

Implement
novel engineering platforms to alter the expression of multiple genes
 

Advance
the discovery & development of TCR-based therapeutics to fight solid tumours

Master
effective specificity & durability with
in vivo CAR-T engineering  

Develop
novel therapies that harness the innate immune system

Bypass
the immunosuppressive solid tumour microenvironment with armouring

Advanced
Clinical Development

Explore
cell therapy products in the clinic for hard to treat indications
 

Implement
innovative mechanisms to enhance persistence & durability 
 

Enhance
efficacy in the clinic with alternative immunomodulation strategies
 

Highlight
opportunities for CAR-TCR therapies beyond oncology

Improve
clinical results through design management & strategy

Predict
treatment efficacy by assessing clinical biomarkers

Identify
opportunities to improve clinical trial design 

Streamlined Manufacturing Platforms

Reduce
production timelines to improve speed to patient

Optimise
cell quality throughout the manufacturing process

Tackle
the bottlenecks when utilising viral vectors

Utilise
new equipment to simplify manufacturing processes

Unify
cell therapy logistics & manufacturing to standardise processes

Improve
analytical & process development to reduce manufacturing costs

Develop
automated, closed & GMP-compliant solutions to scale-up manufacturing 


“I have been part of the CAR-TCR Summit Europe before and I found this to be a well-orchestrated event. It brings the brains together with technology exhibitions and the organisers are helpful and welcoming.”

Hemant Dhamne, Head of Process Development, Gene Therapy Vector Facility, King’s College London

The CAR-TCR Series:

The CAR-TCR Event Series is committed to delivering an exclusive platform to unite the community and explore the key challenges to your industry, guided by global thought leaders in each discipline.

Dedicated to the development of safe, clinically effective and globally accessible therapies, the series is an unrivalled opportunity to gather with experts in your discipline.

From next-generation development to supply chain and logistics, and exploring challenges specific to each area, we create these forums to deliver value and in-depth learnings across the development pipeline, on a global stage.

Other Events in the Series:

Follow Us on Twitter for the Latest CAR-TCR News:


“Working in cell therapy is a dream come true for me to combine my love for research with the passion to make a meaningful difference in the lives of cancer patients. Conferences like CAR-Summit Europe provide an effective platform to expand my knowledgebase, raise awareness and provide a chance to share learnings with fellow researchers.”

Mamta Kalra, Senior Director, CMC, Immatics